Table 3.
Overall (n=350) | Men (n=178) | Women (n=172) | p value | ||
---|---|---|---|---|---|
Incidence of acute dermatolymphangioadenitis episodes* (95% CI) | 21·6 (21·3–21·9) | 20·9 (20·4–21·3) | 22·4 (21·9–22·9) | <0·0001 | |
Ratio of acute dermatolymphangioadenitis incidence, intervention to control groups (95% CI) | 0·81 (0·69–0·96) | 0·73 (0·64–0·84) | 0·90 (0·79–1·02) | <0·0001 | |
Adherence | |||||
To overall intervention | 95·4% (94·6–96·1) | 95·4% (94·7–96·1) | 95·3% (94·4–96·1) | 0·79 | |
To washing with soap | 98·6% (98·2–99·1) | 98·5% (97·9–99·0) | 98·9% (98·4–99·3) | 0·27 | |
To applying ointment | 98·0% (97·4–98·8) | 97·9% (97·2–98·6) | 98·2% (97·5–99·0) | 0·48 | |
To leg elevation | 97·4% (96·3–98·4) | 97·7% (96·9–98·5) | 97·0% (95·7–98·3) | 0·34 | |
To exercises | 97·3% (96·4–98·2) | 97·6% (96·8–98·3) | 97·0% (96·0–98·1) | 0·40 | |
To wearing socks | 87·2% (84·8–89·5) | 87·1% (84·9–89·3) | 87·2% (84·7–89·6) | 0·98 | |
To wearing shoes | 93·6% (92·4–94·9) | 93·8% (92·7–95·0) | 93·4% (92·1–94·7) | 0·60 |
Data are mean proportion (95% CI), unless otherwise indicated. These data are based on adherence records collected from participants in the intervention group only, which are from reported data from the previous month (at 3, 6, 9, and 12 months).
Episodes per person-year.